Strides Pharma Science Ltd
NSE:STAR
Intrinsic Value
Strides Pharma Science Ltd. engages in the development, manufacture and distribution of Internet Protocol-led generics and bio-pharmaceutical products. [ Read More ]
The intrinsic value of one
STAR
stock under the Base Case scenario is
855.11
INR.
Compared to the current market price of 858.45 INR,
Strides Pharma Science Ltd
is
Fairly Valued.
Strides Pharma Science Ltd's market capitalization is 77.5B INR.
STAR stock price is 858.45 INR.
STAR stock (855.11 INR) is 0% less than its price (858.45 INR).
STAR stock (588.64 INR) is 31% less than its price (858.45 INR). Open DCF Valuation
STAR stock price (858.45 INR) is 23% less than its Relative Value (1 121.58 INR). Open Relative Valuation
STAR has downside potential of 0% compared to the average analyst price target.
Open Wall St Estimates
STAR's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 10%.
STAR's short-term assets (34B INR) exceed its short-term liabilties (31B INR).
STAR's ROIC (Return on Invested Capital) has increased in the last 3 years from 7% to 10%.
STAR's Revenue has grown by 11% over the past 12 months.
STAR has positive Free Cash Flow for the last twelve months.
STAR's Revenue is forecast to grow at a rate of 11% per year over the next 3 years.
STAR's Revenue has been growing by 9% per year for the last 3 years.
STAR has positive Operating Income for the last twelve months.
STAR's long-term assets (63B INR) exceed its long-term liabilties (43B INR).
STAR has positive Net Debt. This means that the company has more debt (11B INR) than cash and short-term investments (4B INR).
STAR's ROE (Return on Equity) for the past 12 months is negative and is equal to -4%.
STAR's ROE (Return on Equity) has significantly decreased in the last 3 years from 10% to -4%.
STAR's Altman Z-Score is equal to 2.07.
STAR has negative Net Income for the last twelve months.
STAR has negative three-year average ROIC (Return on Invested Capital): -1%. The company is not efficient at using invested capital to generate operating income.
STAR's D/E (Debt to Equity) is very low and is equal to 0.51.
STAR has positive Gross Profit for the last twelve months.
STAR has negative three-year average ROE (Return on Equity): -7%. The company is not efficient at transforming stockholders' equity into net income.
STAR generates enough operating income (4B INR) to cover interest payments on its debt (3B INR).
Valuation Backtest
Strides Pharma Science Ltd
Run backtest to discover the historical profit from buying and selling
STAR
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Strides Pharma Science Ltd
Balance Sheet Decomposition
Strides Pharma Science Ltd
| Current Assets | 33.9B |
| Cash & Short-Term Investments | 4.3B |
| Receivables | 12.9B |
| Other Current Assets | 16.7B |
| Non-Current Assets | 29.5B |
| Long-Term Investments | 5B |
| PP&E | 9.7B |
| Intangibles | 10.5B |
| Other Non-Current Assets | 4.2B |
| Current Liabilities | 31.4B |
| Accounts Payable | 9.4B |
| Other Current Liabilities | 22B |
| Non-Current Liabilities | 11.5B |
| Long-Term Debt | 10.5B |
| Other Non-Current Liabilities | 932m |
Earnings Waterfall
Strides Pharma Science Ltd
|
Revenue
|
39.5B
INR
|
|
Cost of Revenue
|
-16.2B
INR
|
|
Gross Profit
|
23.3B
INR
|
|
Operating Expenses
|
-18.9B
INR
|
|
Operating Income
|
4.4B
INR
|
|
Other Expenses
|
-5.4B
INR
|
|
Net Income
|
-983.3m
INR
|
Free Cash Flow Analysis
Strides Pharma Science Ltd
STAR Profitability Score
Profitability Due Diligence
Strides Pharma Science Ltd's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
Score
Strides Pharma Science Ltd's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
STAR Solvency Score
Solvency Due Diligence
Strides Pharma Science Ltd's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Score
Strides Pharma Science Ltd's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
STAR Price Targets Summary
Strides Pharma Science Ltd
According to Wall Street analysts, the average 1-year price target for
STAR
is 854.25 INR
with a low forecast of 717.1 INR and a high forecast of 1 013.25 INR.
Shareholder Return
STAR Price
Strides Pharma Science Ltd
| Average Annual Return | 16% |
| Standard Deviation of Annual Returns | 87.36% |
| Max Drawdown | -73% |
| Market Capitalization | 77.5B INR |
| Shares Outstanding | 91 636 500 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Strides Pharma Science Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Strides Pharma Science Ltd. engages in the development, manufacture and distribution of Internet Protocol-led generics and bio-pharmaceutical products. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2000-02-03. The firm is focused on development and manufacture of IP-led niche and pharmaceutical products. The company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The firm manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as, liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. The company has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). The company is also engaged in manufacturing soft gelatin capsules. The company develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
Contact
IPO
Employees
Officers
The intrinsic value of one
STAR
stock under the Base Case scenario is
855.11
INR.
Compared to the current market price of 858.45 INR,
Strides Pharma Science Ltd
is
Fairly Valued.
You don't have any saved screeners yet
